126 related articles for article (PubMed ID: 1348895)
21. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
22. Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy.
Ikeda K; Haga C; Kosaka K; Oyanagi S
Acta Neuropathol; 1989; 78(2):137-42. PubMed ID: 2473593
[TBL] [Abstract][Full Text] [Related]
23. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin.
Janciauskiene S; Eriksson S; Wright HT
Nat Struct Biol; 1996 Aug; 3(8):668-71. PubMed ID: 8756322
[No Abstract] [Full Text] [Related]
24. Distribution of the protease inhibitor alpha 1-antichymotrypsin in cerebral and systemic amyloid.
Picken MM; Larrondo-Lillo M; Coria F; Gallo GR; Shelanski ML; Frangione B
J Neuropathol Exp Neurol; 1990 Jan; 49(1):41-8. PubMed ID: 1688925
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease.
Wisniewski HM; Wegiel J; Wang KC; Lach B
Acta Neuropathol; 1992; 84(2):117-27. PubMed ID: 1381856
[TBL] [Abstract][Full Text] [Related]
26. Tubuloreticular structures in microglial cells, pericytes and endothelial cells in Alzheimer's disease.
Wegiel J; Wisniewski HM
Acta Neuropathol; 1992; 83(6):653-8. PubMed ID: 1636381
[TBL] [Abstract][Full Text] [Related]
27. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
[TBL] [Abstract][Full Text] [Related]
28. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.
Abraham CR; Shirahama T; Potter H
Neurobiol Aging; 1990; 11(2):123-9. PubMed ID: 2190106
[TBL] [Abstract][Full Text] [Related]
29. Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?
Furby A; Leys D; Delacourte A; Buee L; Soetaert G; Petit H
J Neurol Neurosurg Psychiatry; 1991 May; 54(5):469. PubMed ID: 1713952
[No Abstract] [Full Text] [Related]
30. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.
Potter H; Wefes IM; Nilsson LN
Neurobiol Aging; 2001; 22(6):923-30. PubMed ID: 11755000
[TBL] [Abstract][Full Text] [Related]
31. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy.
Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
Ann Neurol; 1998 Jul; 44(1):129-31. PubMed ID: 9667601
[TBL] [Abstract][Full Text] [Related]
32. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism.
Ritchie A; Morgan K; Kalsheker N
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):88-92. PubMed ID: 15530656
[TBL] [Abstract][Full Text] [Related]
33. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
[TBL] [Abstract][Full Text] [Related]
34. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
[TBL] [Abstract][Full Text] [Related]
35. Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease.
Eikelenboom P; Hack CE; Kamphorst W; Rozemuller JM
Res Immunol; 1992; 143(6):617-20. PubMed ID: 1455052
[No Abstract] [Full Text] [Related]
36. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates.
Huang Y; Herman MM; Liu J; Katsetos CD; Wills MR; Savory J
Brain Res; 1997 Oct; 771(2):213-20. PubMed ID: 9401741
[TBL] [Abstract][Full Text] [Related]
37. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
38. Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils?
Inoue S; Kisilevsky R
Ital J Anat Embryol; 2001; 106(2 Suppl 1):93-102. PubMed ID: 11730002
[TBL] [Abstract][Full Text] [Related]
39. [Abnormal proteins in the brain in Alzheimer's disease].
Kanemaru K; Ihara Y
Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
[No Abstract] [Full Text] [Related]
40. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
Ikeda S; Allsop D; Glenner GG
Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
